Positive Data from Trial of Investigational Treatment KZR-616 for Lupus and Lupus Nephritis
June 3, 2020
Kezar Life Sciences, Inc. today announced updated results from the Phase 1b (Ph1b) portion of MISSION, a...
Kezar Life Sciences
Lupus Research Alliance
